These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22548114)

  • 1. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases.
    Viganò S; Perreau M; Pantaleo G; Harari A
    Clin Dev Immunol; 2012; 2012():485781. PubMed ID: 22548114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular insights into T cell exhaustion.
    Wherry EJ; Kurachi M
    Nat Rev Immunol; 2015 Aug; 15(8):486-99. PubMed ID: 26205583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion during persistent viral infections.
    Kahan SM; Wherry EJ; Zajac AJ
    Virology; 2015 May; 479-480():180-93. PubMed ID: 25620767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-surveillance through exhausted effector T-cells.
    Zehn D; Utzschneider DT; Thimme R
    Curr Opin Virol; 2016 Feb; 16():49-54. PubMed ID: 26826950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of T Cell Coinhibitory Molecules on CD8
    Morris AB; Adams LE; Ford ML
    Front Immunol; 2018; 9():1810. PubMed ID: 30135685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative signaling contributes to T-cell anergy in trauma patients.
    Bandyopadhyay G; De A; Laudanski K; Li F; Lentz C; Bankey P; Miller-Graziano C
    Crit Care Med; 2007 Mar; 35(3):794-801. PubMed ID: 17255857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
    Ceeraz S; Nowak EC; Burns CM; Noelle RJ
    Arthritis Res Ther; 2014; 16(5):469. PubMed ID: 25606596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!
    Khan N; Gowthaman U; Pahari S; Agrewala JN
    PLoS Pathog; 2012; 8(6):e1002676. PubMed ID: 22719245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 stimulation in vivo does not inhibit CD4+ T cell tolerance to soluble antigens.
    Sun J; Van Houten N
    Immunol Lett; 2002 Nov; 84(2):125-32. PubMed ID: 12270549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.
    Kirchberger S; Majdic O; Steinberger P; Blüml S; Pfistershammer K; Zlabinger G; Deszcz L; Kuechler E; Knapp W; Stöckl J
    J Immunol; 2005 Jul; 175(2):1145-52. PubMed ID: 16002716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell Activation.
    Yakoub AM; Schulz R; Seiffert M; Sadek M
    Sci Rep; 2018 Jul; 8(1):10533. PubMed ID: 30002409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses.
    Crawford A; Wherry EJ
    Curr Opin Immunol; 2009 Apr; 21(2):179-86. PubMed ID: 19264470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell anergy: where it's LAT.
    Lineberry N; Fathman CG
    Immunity; 2006 May; 24(5):501-3. PubMed ID: 16713965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells.
    Taams LS; Boot EP; van Eden W; Wauben MH
    J Autoimmun; 2000 Jun; 14(4):335-41. PubMed ID: 10882060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure.
    Vigano S; Bobisse S; Coukos G; Perreau M; Harari A
    Front Immunol; 2020; 11():1350. PubMed ID: 32714330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of regulatory cells CD4+CD25+ in the development of chronic infective diseases].
    Vorob'ev AA; Bykovskaia SN; Pashkov EP; Bykov AS
    Vestn Ross Akad Med Nauk; 2006; (9-10):24-9. PubMed ID: 17111920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
    Bendiksen S; Rekvig OP
    Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
    Verhoef A; Lamb JR
    J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.